Moderna Inc said on Wednesday it has enough data for a first interim analysis of the late-stage trial of its experimental COVID-19 vaccine, which should help determine the vaccine's efficacy.

Moderna said the information is being prepared for submission to the trial's independent data safety monitoring board, which will look at the results and make a recommendation. It did not say when it plans to release the efficacy data.

The company said in a news release that it has seen a significant increase in the number of COVID-19 cases among trial participants as infection rates have surged around the United States.

Due to the spike in cases, the analysis will cover substantially more than 53 infections, which had been the targeted trigger point for the first analysis.

The company said the trial remains blinded, so neither it nor study investigators know which participants received the vaccine or a placebo. The vaccine will be deemed a success if the overwhelming majority of those infected had received a placebo, once the monitoring board looks at the early results.

Earlier in the day, Dr. Anthony Fauci, the top U.S. infectious disease expert, said Moderna could have the data from anywhere between "a couple of days" to "a little more than a week."

A high degree of effectiveness would make sense as it is "almost identical" to Pfizer Inc's experimental vaccine, Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, said at a conference organized by the Financial Times.

"It may not be 95%, it might be 90%, or 96%, or 89%, but it is going to be up there," he said.

Pfizer on Monday said its COVID-19 vaccine was more than 90% effective based on interim trial results, significantly higher than the at least 50% efficacy regulators are looking for.

Moderna, which uses a similar messenger RNA technology as Pfizer, said earlier on Wednesday that its November timeline for initial data was on track.

It did not respond to a Reuters request for comment on when it would disclose the data.

The company would still have to wait for two-month follow-up safety data required by the U.S. Food and Drug Administration, which it expects to have in the second half of this month, before applying for U.S. emergency use authorization.

There are no vaccines that have gained global approval yet, although a handful, including Moderna's, are in late-stage studies.

Moderna's shares closed up 8.4% at $82.44 and rose to $83.85 in extended trading



Another vaccine results coming out soon. Beware to all glove lover and shareholders.

Moderna Inc said on Wednesday it has enough data for a first interim analysis of the late-stage trial of its experimental COVID-19 vaccine, which should help determine the vaccine's efficacy.

Moderna said the information is being prepared for submission to the trial's independent data safety monitoring board, which will look at the results and make a recommendation. It did not say when it plans to release the efficacy data.

The company said in a news release that it has seen a significant increase in the number of COVID-19 cases among trial participants as infection rates have surged around the United States.

Due to the spike in cases, the analysis will cover substantially more than 53 infections, which had been the targeted trigger point for the first analysis.

The company said the trial remains blinded, so neither it nor study investigators know which participants received the vaccine or a placebo. The vaccine will be deemed a success if the overwhelming majority of those infected had received a placebo, once the monitoring board looks at the early results.

Earlier in the day, Dr. Anthony Fauci, the top U.S. infectious disease expert, said Moderna could have the data from anywhere between "a couple of days" to "a little more than a week."

A high degree of effectiveness would make sense as it is "almost identical" to Pfizer Inc's experimental vaccine, Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, said at a conference organized by the Financial Times.

"It may not be 95%, it might be 90%, or 96%, or 89%, but it is going to be up there," he said.

Pfizer on Monday said its COVID-19 vaccine was more than 90% effective based on interim trial results, significantly higher than the at least 50% efficacy regulators are looking for.

Moderna, which uses a similar messenger RNA technology as Pfizer, said earlier on Wednesday that its November timeline for initial data was on track.

It did not respond to a Reuters request for comment on when it would disclose the data.

The company would still have to wait for two-month follow-up safety data required by the U.S. Food and Drug Administration, which it expects to have in the second half of this month, before applying for U.S. emergency use authorization.

There are no vaccines that have gained global approval yet, although a handful, including Moderna's, are in late-stage studies.

Moderna's shares closed up 8.4% at $82.44 and rose to $83.85 in extended trading



Another vaccine results coming out soon. Beware to all glove lover and shareholders.

Another lohching company...only can make big money in bursa by buying those lohching company. Gets is another famous lohching company using glove business as their easy way to make billions in bursamalaysia. Bursa now is also part of their accomplish.

Got huge profit still want to wait ? Later drop buy back again laa...simple rule also can't understand ?

Who already catched the falling knife ? Tomorrow continue the catch.

Who already catched the falling knife ? Tomorrow continue the catch.

Who already catched the falling knife ? Tomorrow continue the catch.

Who already catched the falling knife ? Tomorrow continue the catch.

Who already catched the falling knife ? Tomorrow continue the catch.

More downside risk this week for glove stocks, good luck to those glove believers. I'm personally very hopeful that vaccine quickly come out so that everyone could live a normal life again and less unfortunate deaths from covid-19 happened again day and night. Why you so happy to earn lots of money from ppl's suffering ?? GOD bless the world.

More downside risk this week for glove stocks, good luck to those glove believers. I'm personally very hopeful that vaccine quickly come out so that everyone could live a normal life again and less unfortunate deaths from covid-19 happened again day and night. Why you so happy to earn lots of money from ppl's suffering ?? GOD bless the world.

More downside risk this week for glove stocks, good luck to those glove believers. I'm personally very hopeful that vaccine quickly come out so that everyone could live a normal life again and less unfortunate deaths from covid-19 happened again day and night. Why you so happy to earn lots of money from ppl's suffering ?? GOD bless the world.

More downside risk this week for glove stocks, good luck to those glove believers. I'm personally very hopeful that vaccine quickly come out so that everyone could live a normal life again and less unfortunate deaths from covid-19 happened again day and night. Why you so happy to earn lots of money from ppl's suffering ?? GOD bless the world.

It is clear that glove stocks are not immune to vaccine news. More positive news about vaccine coming out soon so beware for those who still holding glove stocks. Expect more bumpy rides after this.

It is clear that glove stocks are not immune to vaccine news. More positive news about vaccine coming out soon so beware for those who still holding glove stocks. Expect more bumpy rides after this.

It is clear that glove stocks are not immune to vaccine news. More positive news about vaccine coming out soon so beware for those who still holding glove stocks. Expect more bumpy rides after this.

It is clear that glove stocks are not immune to vaccine news. More positive news about vaccine coming out soon so beware for those who still holding glove stocks. Expect more bumpy rides after this.

DJ up 1500 points because of vaccine news...bad news for all glove stocks. Bad timing for AT, good luck to those who bought AT.

Today oil stocks rally...get ready for the spike

Today oil stocks rally...get ready for the spike

Today oil stocks rally...get ready for the spike

Today profit taking as vaccine news is out ??

Today profit taking as vaccine news is out ??

Today profit taking as vaccine news is out ??

Limit up....buy !

Limit up...buy !

Tomorrow limit up....buy !

Tomorrow limit up...buy !

Today should reach 45 cents at least

Gdex, POS and Natwide going up tomorrow...get ready

https://www.thestar.com.my/business/business-news/2020/11/06/winners-and-losers-from-budget-2021

BAT one of the big loser. Pls don't try to twist the fact.

Surely and definitely

CMCO on Monday means another limit up for Natwide

Monday limit up again...buy early

Ready to buy more if drop below 0.40

Buy and keep now before the release of the next few QR. TP0.80 b4 year-end.

KUALA LUMPUR (Nov 6): Following the release of the RM322.5 billion Budget 2021, Malaysia’s largest national budget on record, AmInvestment Bank Research's top stock picks are Malayan Banking Bhd (Maybank), Tenaga National Bhd (TNB), Axiata Group Bhd, Dialog Group Bhd, RHB Bank Bhd, Westports Holdings Bhd, Malaysia Airports Holdings Bhd (MAHB), Allianz Malaysia Bhd, MMC Corp Bhd and Kumpulan Powernet Bhd (KPower).

Why never mentioned about BAT ??

Williamh pls help push to limit up okay ?

The number of covid-19 cases may reach few hundreds soon just like what happened in prison and Singapore.

The number may reach few hundreds soon just like what happened in prison and Singapore.

Today closing at least 1.00

Line up 500 lot at 39 cents... hope can get.

Dow Jones up 550 and future up 220 points. All green today.

Dow Jones up 550 and future up 220 points. All green today.

11.11 celebration this year must be the biggest so far in Malaysia...really a very good news for GDEX.

More lockdown means more businesses for POS and Gdex, either locally or internationally

Next pushing towards 1.20 soon...Alibaba businesses is coming to Malaysia in a big way. Celebration of mega sales on 11.11 is under way.

More lockdown means more businesses for Gdex, either locally or internationally

Wu master is accumulating Gdex...TP50¢

Airport RM5 coming soon

https://www.klsescreener.com/v2/news/view/748311